European Bioanalysis Forum Recommendation on Method Establishment And Bioanalysis of Biomarkers in Support of Drug Development
- 1 August 2012
- journal article
- guideline
- Published by Taylor & Francis in Bioanalysis
- Vol. 4 (15) , 1883-1894
Abstract
Biomarkers have become increasingly important in drug development and many bioanalysts are getting involved. Consequently, different views on how to approach the bioanalysis of biomarkers have been published or are being developed. The European Bioanalysis Forum has intensively discussed this topic since 2010 and is ready with their recommendation on method establishment and bioanalysis of biomarkers. Acknowledging that the challenges step outside the bioanalytical laboratory is a cornerstone of our recommendation. The importance of integrating all scientific aspects, from purely analytical aspects, all the way to understanding the biology and effects of the biomarker, prior to embarking on method establishment or sample analysis, cannot be underestimated. Close and iterative interactions with the teams requesting the data is imperative to develop a bioanalytical strategy that combines science, analytical performance and regulations. The European Bioanalysis Forum developed a straightforward decision tree to help the scientific community in developing a bioanalytical strategy for any biomarker in drug development.Keywords
This publication has 10 references indexed in Scilit:
- Conference Report: ‘Less Is More‘: Defining Modern BioanalysisBioanalysis, 2012
- Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis ForumBioanalysis, 2010
- Generic Approach to Validation of Small-Molecule LC–MS/MS Biomarker AssaysBioanalysis, 2009
- Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assaysThe AAPS Journal, 2007
- The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes2007
- Fit-for-Purpose Method Development and Validation for Successful Biomarker MeasurementPharmaceutical Research, 2006
- Mechanism-Based Pharmacokinetic–Pharmacodynamic Modeling—A New Classification of BiomarkersPharmaceutical Research, 2005
- Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of MacromoleculesPharmaceutical Research, 2003
- Use of Biomarkers and Surrogate Endpoints in Drug Development and Regulatory Decision Making: Criteria, Validation, StrategiesAnnual Review of Pharmacology and Toxicology, 2001
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001